Figure 5.

Response for patients and caregivers for pediatric patients: (a) Hemo-Sat and (b) CHO-KLAT.

There were general improvements associated with treatment burden from the perspective of both the pediatric patient and their caregiver. Large data point markers indicate significant results (p value <0.05 comparison to A-LONG baseline). Treatment regimen prior to enrolling in A-LONG. Hemo-Sat, hemophilia-specific treatment satisfaction questionnaire; CHO-KLAT, Canadian Haemophilia Outcomes – Kids’ Life Assessment Tool; Hemo-Sat, hemophilia-specific treatment satisfaction questionnaire.